Cogent Biosciences Inc’s recent filing unveils that its Director Fairmount Funds Management LLC acquired Company’s shares for reported $25.0 million
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Cogent Biosciences Inc’s filing revealed that its Director Fairmount Funds Management LLC acquired Company’s shares for reported $25.0 million on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or